32 related articles for article (PubMed ID: 31593805)
1. Anti-inflammatory Fucoidan-ConA oral insulin nanosystems for smart blood glucose regulation.
Zhou J; Ma H; Guan M; Feng J; Dong X; Wei Y; Zhang T
Int J Pharm; 2024 Jun; 659():124250. PubMed ID: 38777304
[TBL] [Abstract][Full Text] [Related]
2. Oral insulin delivery by means of solid lipid nanoparticles.
Sarmento B; Martins S; Ferreira D; Souto EB
Int J Nanomedicine; 2007; 2(4):743-9. PubMed ID: 18203440
[TBL] [Abstract][Full Text] [Related]
3. Construction of resveratrol and quercetin nanoparticles based on folic acid targeted Maillard products between Jiuzao glutelin isolate and carboxymethyl chitosan: Improved stability and function.
Jiang Y; Xing M; Sun J; Zeng XA; Brennan C; Chandrapala J; Majzoobi M; Sun B
Food Chem; 2024 Aug; 450():139296. PubMed ID: 38636381
[TBL] [Abstract][Full Text] [Related]
4. Assessment of poly(methacrylic acid-co-N-vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco-2 and HT29-MTX cell lines.
Carr DA; Peppas NA
J Biomed Mater Res A; 2010 Feb; 92(2):504-12. PubMed ID: 19213059
[TBL] [Abstract][Full Text] [Related]
5. Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.
Karathanasis E; Bhavane R; Annapragada AV
Int J Nanomedicine; 2007; 2(3):501-13. PubMed ID: 18019848
[TBL] [Abstract][Full Text] [Related]
6. A review on oral novel delivery systems of insulin through the novel delivery system formulations: A review.
Limenh LW
SAGE Open Med; 2024; 12():20503121231225319. PubMed ID: 38249950
[TBL] [Abstract][Full Text] [Related]
7. A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil.
Akbar MU; Khattak S; Khan MI; Saddozai UAK; Ali N; AlAsmari AF; Zaheer M; Badar M
Front Pharmacol; 2023; 14():1265440. PubMed ID: 37745070
[TBL] [Abstract][Full Text] [Related]
8. Zein-Based Nanoparticles as Oral Carriers for Insulin Delivery.
Reboredo C; González-Navarro CJ; Martínez-López AL; Martínez-Ohárriz C; Sarmento B; Irache JM
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056935
[TBL] [Abstract][Full Text] [Related]
9. Formulation and Evaluation of Topical Biodegradable Films Loaded with Levofloxacin Lipid Nanocarriers.
Abdel-Rashid RS; El-Leithy ES; Abdel-Monem R
AAPS PharmSciTech; 2021 Dec; 23(1):34. PubMed ID: 34950989
[TBL] [Abstract][Full Text] [Related]
10. Role of Vitamin B12 and Folate in Metabolic Syndrome.
Ashok T; Puttam H; Tarnate VCA; Jhaveri S; Avanthika C; Trejo Treviño AG; Sl S; Ahmed NT
Cureus; 2021 Oct; 13(10):e18521. PubMed ID: 34754676
[TBL] [Abstract][Full Text] [Related]
11. Can nanoparticles and nano‒protein interactions bring a bright future for insulin delivery?
Zhang T; Tang JZ; Fei X; Li Y; Song Y; Qian Z; Peng Q
Acta Pharm Sin B; 2021 Mar; 11(3):651-667. PubMed ID: 33777673
[TBL] [Abstract][Full Text] [Related]
12. Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit
Lee SH; Back SY; Song JG; Han HK
J Nanobiotechnology; 2020 Jul; 18(1):104. PubMed ID: 32711522
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
14. Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.
Li X; Qi J; Xie Y; Zhang X; Hu S; Xu Y; Lu Y; Wu W
Int J Nanomedicine; 2013; 8():23-32. PubMed ID: 23293517
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
[TBL] [Abstract][Full Text] [Related]
16. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.
Chaudhury A; Das S
AAPS PharmSciTech; 2011 Mar; 12(1):10-20. PubMed ID: 21153572
[TBL] [Abstract][Full Text] [Related]
17. Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.
Geho WB; Geho HC; Lau JR; Gana TJ
J Diabetes Sci Technol; 2009 Nov; 3(6):1451-9. PubMed ID: 20144401
[TBL] [Abstract][Full Text] [Related]
18. Folate-chitosan nanoparticles triggered insulin cellular uptake and improved in vivo hypoglycemic activity.
El Leithy ES; Abdel-Bar HM; Ali RA
Int J Pharm; 2019 Nov; 571():118708. PubMed ID: 31593805
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
